Experiment 445739

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationEXTRA,JM: ROUSSEAU,F: BRUNO,R: CLAVEL,M: LE BAIL,N: MARTY,M:. (1993). PHASE I AND PHARMACOKINETIC STUDY OF TAXOTERE (RP 56076; NSC 628503) GIVEN AS A SHORT INTRAVENOUS INFUSION.. 53(5)
Amount utilized
Compound isolated
DiseaseAT THE HIGHEST DOSES, THE TAXOTERE PLASMA PROFILE WAS TYPICALLY TRIPHASIC WITH A TERMINAL HALF-LIFE OF 13.5 HOURS, A PLASMA CLEARANCE OF 21.1 LITERS/HOUR/SQ.M. AND A DISTRIBUTION VOLUME OF 72 LITERS/SQ.M. RENAL EXCRETION OF TAXOTERE WAS <5%.
Dose amountVAR
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE